Biogen
BIIB
BIIB
946 hedge funds and large institutions have $49.3B invested in Biogen in 2016 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 363 increasing their positions, 350 reducing their positions, and 103 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less funds holding in top 10
Funds holding in top 10: 37 → 32 (-5)
16% less capital invested
Capital invested by funds: $58.9B → $49.3B (-$9.59B)
Holders
946
Holding in Top 10
32
Calls
$1.05B
Puts
$1.13B
Top Buyers
| 1 | +$458M | |
| 2 | +$148M | |
| 3 | +$114M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$99.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$89.1M |
Top Sellers
| 1 | -$162M | |
| 2 | -$139M | |
| 3 | -$137M | |
| 4 |
JP Morgan Chase
New York
|
-$135M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$99.9M |